UNC Lineberger member Andrew Wang, MD, was senior author of a preclinical study published in the journal ACS Nano. Wang and collaborators found that they could improve cancer chemotherapy and chemoradiotherapy treatments by delivering a combination of cancer-fighting drugs using nanoparticles.
The use of robot-assisted surgery and modern radiation techniques have been rapidly adopted as treatments for prostate cancer, but a UNC Lineberger Comprehensive Cancer Center researcher is asking what the newer technologies will mean in terms of side effects and outcomes for patients in the long-term.
A new microbeam emitter developed at the University of North Carolina at Chapel Hill by a team led by UNC Lineberger member Otto Zhou has the potential to bring a promising new form of radiation therapy into clinical use.
Five questions for Ronald Chen, a James Woods Young Faculty Award recipient dedicated to bettering treatment for cancer patients.